首页> 外文期刊>Clinics and research in hepatology and gastroenterology. >Treatment of primary biliary cholangitis with ursodeoxycholic acid, prednisolone and immunosuppressants in patients not responding to ursodeoxycholic acid alone and the prognostic indicators
【24h】

Treatment of primary biliary cholangitis with ursodeoxycholic acid, prednisolone and immunosuppressants in patients not responding to ursodeoxycholic acid alone and the prognostic indicators

机译:用熊去氧胆酸、泼尼松龙和免疫抑制剂治疗原发性胆汁性胆管炎对单独使用熊去氧胆酸无反应的患者及其预后指标

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Background and aim: We reviewed the medical records of primary biliary cholangitis patients who were diagnosed by liver biopsy and treated with the corresponding treatment. We evaluated the therapeutic effect and long-term prognostic indicators.
机译:背景和目的: 我们回顾了经肝活检诊断并接受相应治疗的原发性胆汁性胆管炎患者的病历。我们评估了治疗效果和远期预后指标。

著录项

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号